Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
MAX-10181
DRUG
2 trials
Sponsors
Maxinovel Pty., Ltd.
Conditions
Solid Tumor
Phase 1
MAX-10181 Given Orally to Patients With Advanced Solid Tumor
NCT04122339
Maxinovel Pty., Ltd.
Solid Tumor
Start: 2020-02-11
End: 2022-11-01
Target: 30
Updated: 2022-01-19
MAX-10181 in Patients With Advanced Solid Tumor
NCT05196360
Maxinovel Pty., Ltd.
Solid Tumor
Start: 2021-08-11
End: 2023-05-01
Target: 80
Updated: 2022-01-19